Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

GlobalFoundries Stock (GFS) Today: Nasdaq-100 Exit, EU Funding Boost, GaN Partnerships, and What Analysts Forecast Next

GlobalFoundries Stock (GFS) Today: Nasdaq-100 Exit, EU Funding Boost, GaN Partnerships, and What Analysts Forecast Next

December 20, 2025 — GlobalFoundries Inc. (NASDAQ: GFS) is heading into year-end with an unusually dense cluster of catalysts for a “specialty foundry” name: an impending removal from the Nasdaq-100, fresh Europe-leaning policy support, a string of power-semiconductor (GaN) partnerships,
Recursion Pharmaceuticals Stock (RXRX) News and Forecasts for Dec. 20, 2025: TUPELO Trial Data, JPMorgan Upgrade, and What Comes Next

Recursion Pharmaceuticals Stock (RXRX) News and Forecasts for Dec. 20, 2025: TUPELO Trial Data, JPMorgan Upgrade, and What Comes Next

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) heads into the weekend of December 20, 2025 with investors still digesting a fast-moving sequence of catalysts: fresh clinical data for its lead program REC-4881, a notable JPMorgan upgrade, and a burst of unusually heavy
1 305 306 307 308 309 594
Go toTop